Severe forms of reversible erythrocytosis in SGLT-2-users without and with concomitant TRT have been described, mainly because of hemoconcentration due to diuresis and direct effects on iron- and/or hepcidin metabolism (19–22). This evidence concerns the gene HAMP and polycythemia.